Thus, the significant decrease in macrophages, monocytes, and CD4+ T cells, but not CD8+ T cells, in tumor centers following central HA degradation highlights both the importance of HA in altering the intratumoral immune repertoire and the effects of YS-HAse treatment in disrupting these interactions. The gene discussed is CD4; the disease is neoplasm.